HA
TRIB

Heartland Advisors’s Trinity Biotech TRIB Stock Holding History

Heartland Advisors’s Portfolio TRIB Stock Details TRIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-3,283
Closed -$995K – 228
2020
Q3 		$995K Sell
3,283
-2,517
-43% -$874K 0.09% 194
2020
Q2 		$1.9M Sell
5,800
-102
-2% -$23.3K 0.17% 159
2020
Q1 		$974K Buy
5,902
+1,510
+34% +$237K 0.1% 170
2019
Q4 		$681K Buy
4,392
+628
+17% +$89.6K 0.05% 175
2019
Q3 		$683K Sell
3,764
-2,134
-36% -$556K 0.05% 173
2019
Q2 		$1.46M Hold
5,898
– – 0.11% 167
2019
Q1 		$2.52M Hold
5,898
– – 0.19% 150
2018
Q4 		$2.03M Buy
5,898
+615
+12% +$285K 0.17% 156
2018
Q3 		$3.17M Sell
5,283
-486
-8% -$317K 0.21% 155
2018
Q2 		$4.33M Sell
5,769
-2,070
-26% -$1.49M 0.29% 140
2018
Q1 		$6.05M Sell
7,839
-1,135
-13% -$929K 0.41% 111
2017
Q4 		$6.87M Sell
8,974
-413
-4% -$319K 0.44% 102
2017
Q3 		$7.9M Sell
9,387
-1,050
-10% -$879K 0.51% 96
2017
Q2 		$9.39M Buy
10,437
+133
+1% +$113K 0.6% 76
2017
Q1 		$9.21M Buy
10,304
+79
+0.8% +$74.1K 0.56% 76
2016
Q4 		$10.6M Buy
10,225
+1,762
+21% +$1.82M 0.59% 75
2016
Q3 		$16.8M Buy
8,463
+106
+1% +$198K 0.96% 22
2016
Q2 		$14.2M Sell
8,357
-243
-3% -$411K 0.8% 41
2016
Q1 		$15M Buy
8,600
+251
+3% +$400K 0.79% 41
2015
Q4 		$14.7M Buy
8,349
+324
+4% +$574K 0.59% 58
2015
Q3 		$13.8M Buy
8,025
+97
+1% +$234K 0.5% 69
2015
Q2 		$21.5M Sell
7,928
-3
-0% -$7.79K 0.6% 50
2015
Q1 		$22.9M Hold
7,931
– – 0.57% 56
2014
Q4 		$20.8M Sell
7,931
-88
-1% -$228K 0.41% 85
2014
Q3 		$22M Sell
8,019
-14
-0.2% -$45.5K 0.43% 90
2014
Q2 		$27.7M Sell
8,033
-80
-1% -$284K 0.48% 74
2014
Q1 		$29.5M Sell
8,113
-60
-0.7% -$236K 0.52% 66
2013
Q4 		$30.8M Sell
8,173
-163
-2% -$587K 0.54% 66
2013
Q3 		$27.2M Sell
8,336
-2,129
-20% -$6.23M 0.5% 72
2013
Q2 		$26.4M Buy
+10,465
New +$26M 0.49% 83

Other funds holding TRIB

Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
HAIM
Hunter Associates Investment Management Pittsburgh, Pennsylvania $868M AUM 32.25% 1-Year Est. Return
SCM
Stonehill Capital Management New York $350M AUM 73.6% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
NA
Navellier & Associates Reno, Nevada $1.26B AUM 95.39% 1-Year Est. Return
SFI
Susquehanna Fundamental Investments Bala Cynwyd, Pennsylvania $5.32B AUM 30.24% 1-Year Est. Return
VF
Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return

Heartland Advisors's TRIB Position: Q4 2020 in Review

Heartland Advisors sold out of Trinity Biotech (TRIB) in Q4 2020, closing a stake of 3,283 shares — an estimated $995K sold.

Heartland Advisors first reported a position in TRIB in Q2 2013 and held it in 30 quarters. The position peaked at $30.8M in Q4 2013. 24 funds tracked by Wall St. Rank hold TRIB as of Q4 2020.

  • Heartland Advisors reported no remaining Trinity Biotech position as of Q4 2020 after selling out during the quarter.
  • Heartland Advisors sold 3,283 Trinity Biotech shares in Q4 2020, an estimated $995K.
  • Heartland Advisors first reported a position in Trinity Biotech in Q2 2013 and held it in 30 quarters.
  • Heartland Advisors's Trinity Biotech position peaked at $30.8M in Q4 2013.
  • 24 funds tracked by Wall St. Rank held Trinity Biotech as of Q4 2020.

Based on Heartland Advisors's 13F filing for Q4 2020, filed 11 Feb 2021.